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BACKGROUND
Internationally, there were 219 million cases of malaria in 2018 
and 435,000 deaths.1 The most important first step in the 
management of patients with malaria is recognition of the diag-
nosis. In a western emergency department (ED), the returning 
traveler with a fever of unknown origin generates a long list of 
potential infectious diseases. To diagnose malaria, for many years, 
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Abstract
Background: Screening for malaria in the returning traveler has often required re-
peat testing; however, audit data suggest that patients have not been reattending. 
We sought to ascertain if this was safe by examining the diagnostic efficacy of a single 
screen consisting of a rapid diagnostic test (RDT) and a thin film.
Methods: We conducted a retrospective cohort study of patients with suspected ma-
laria who attended in the past 5 years from two large teaching hospitals. We assessed 
the diagnostic accuracy of a single screen, reporting measures of sensitivity and speci-
ficity. To establish a reference standard, we cross- linked data with the national malaria 
registry held at Public Health England and regional centers.
Results: The cohort consisted of 1365 patients, of whom 33 opted out of the research 
and one did not have a complete initial screen. Of those 1331 screens there were 74 
cases of Plasmodium falciparum (prevalence of 5.6%) and 104 of any malaria species 
(prevalence of 7.8%). Sensitivity for the detection of P. falciparum was 100.00% (95% 
confidence interval [CI] = 95.1 to 100), with a specificity of 99.4% (95% CI = 98.9 to 
99.8). For the detection of any species of malaria the sensitivity was slightly lower due 
to the presence of one false negative; sensitivity was 99.0% (95% CI = 94.8 to 100) 
and specificity was 99.5% (95% CI = 98.9 to 99.8).
Conclusions: A single thin film and RDT is likely to be sufficient as a first screen for 
falciparum malaria in the returning traveler with important caveats. For those sent 
home from emergency departments, appropriate safety netting must be provided. 
Further prospective study is required to investigate this approach.
K E Y W O R D S
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the use of serial thick or thin films has been the reference standard 
for diagnosis.2
The most recent Hematology Task Force guidelines recommend 
that when there is a strong clinical suspicion of malaria but the initial 
films are negative, repeat films should be made and examined after 12 
to 24 h and again after an additional 24 h.3 For patients presenting to 
the ED who are discharged home, obtaining repeat films would require 
return visits to ambulatory care or outpatient clinics. This results in a 
cost and time implication for both the patient and the hospital.
In a Cochrane review, Abba et al.4 described rapid diagnostic tests 
(RDTs) by categories according to antigen targets. BinaxNOW is a type 
2 RDT, meaning that it detects the presence of histidine- rich protein 
(HRP- 2) and aldolase, allowing the detection of Plasmodium falciparum, 
or nonfalciparum species or a mixed infection with P. falciparum plus a 
nonfalciparum species.4 In their meta- analysis of the use of type 2 RDTs 
in endemic countries for the detection of P. falciparum they demon-
strated a sensitivity of 96.0% (95% confidence interval [CI] = 94.0% to 
97.3%). In lower- prevalence settings the diagnostic accuracy appears to 
persist with stand- alone RDT strategies, with sensitivities ranging from 
93.3% to 97.7%. However, the parasitemias of the samples to which 
these sensitivities apply were not stated.4- 7 These parasitemias are use-
ful to contextualize the diagnostic accuracy of the RDT. Hypothetically, 
malaria may be more difficult to detect in low- parasitemia populations.
Since their introduction, RDTs have frequently been combined 
with microscopy in current clinical practice. This potentially allows 
an improved diagnostic sensitivity that may obviate the need for 
repeat testing on every patient, reducing inconvenience for them, 
improving efficiency for health services, and reducing the associated 
cost of repeat testing. The safety netting that is a core part of medi-
cal practice could be utilized here to direct patients to return if they 
feel unwell, potentially mitigating the harm from false negatives.
A local audit in a major teaching hospital ED examined the ad-
herence to the malaria diagnostic standard of three serial screens 
over 72 hours over 10 years. During that time only 5.8% had the 
recommended three blood tests. These numbers were concerning; 
patients appeared to be opting not to return. This led us to question 
whether mandating repeat tests was truly clinically necessary. In 
this study we aimed to determine the diagnostic efficacy of a com-
bined blood film and simultaneous RDT strategy, for the detection 
of Plasmodium falciparum and nonfalciparum malaria parasites in the 
setting of real- world practice of an ED.
METHODS
Study design and setting
We undertook a retrospective diagnostic accuracy study at 
Manchester Royal Infirmary and Royal Manchester Children's 
Hospital, both of which are large university- affiliated major trauma 
centers situated in the northwest of England. Approval was obtained 
from the research ethics committee (19/NW/0236), and the confi-
dentiality advisory group (19/CAG/0027).
Participants
We included all patients with suspected malaria who attended the 
adult or pediatric EDs at Manchester University NHS Foundation 
Trust over a 5- year period (2014– 2019). Participants were identi-
fied from the laboratory database if they underwent testing for sus-
pected malaria.
Index test
The patients are selected by emergency medicine clinicians who 
are suspicious of a diagnosis of infection by Plasmodium spp. This 
is defined by departmental guidelines as a returning traveler from 
an endemic area, with a fever or who is generally unwell. The 
clinical diagnostic pathway at the hospital mandated that each 
malaria test should consist of a thin film and RDT (BinaxNOW). 
The Manchester hospitals used BinaxNOW during the period of 
this study, regularly reviewing the test performance data. The 
blood film was examined by two trained laboratory biomedical 
scientists, only the final consensus result was recorded. Either 
a positive RDT or a positive film required samples to be sent to 
the local reference center, where thin and thick blood films were 
examined.
Reference standard
We retrieved all results of serial testing for malaria from local da-
tabases. Normal clinical practice in our unit dictates that all posi-
tive results are sent to the local reference center for confirmation 
of diagnosis and malarial species. The study database was then 
cross- referenced with the national malaria registry held at Public 
Health England (PHE). Diagnostic laboratories in England, Northern 
Ireland, and Wales are required to report positive malaria tests the 
PHE Malaria Reference Laboratory [MRL]).8 For cases in Scotland, 
reporting is to Health Protection Scotland. In the event of a negative 
screen, we examined any serial testing that had been conducted lo-
cally to identify in discrepancies.
Due to the high mortality and morbidity associated with P. falci-
parum an assumption was made that patients who originally tested 
negative would likely re- present and that the national registry could 
then be used to identify false negatives. A further assumption was 
made that patients infected with other species of malaria, but tested 
negative initially, would represent due to ongoing illness and uni-
versal free health care from the United Kingdom's National Health 
Service.
Data collection
The local clinical database was used to extract the malaria screen 
results, regional center verification, demographics, physiologic 
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parameters, and full blood counts. The data were then collated in a 
central database for analysis.
Data analysis
The sample size was determined by the availability of relevant data. 
We planned to conduct measures of diagnostic accuracy including 
sensitivity, specificity, and positive and negative predictive values.
RESULTS
Over a 5- year period between March 2014 and 2019, a total of 2199 
screens were conducted for 1365 unique patients. Thirty- three pa-
tients had requested that their records be excluded from research 
via a national opt- out program. Of those patients, only one was ex-
cluded for an incomplete initial screen, this left 1331 with a complete 
first screen (Figure 1). A total of 51.3% were male, and the average 
age was 30.6 years (range = 4 months to 89 years old; Table 1). There 
were 104 positive results from complete initial screens. Of those, 
103 were single organisms, 74 were positive for P. falciparum, 23 
P. vivax, six P. ovale, and one a mixed infection of P. falciparum with 
P. ovale. Of the completed and verified first screens, the background 
prevalence of P. falciparum was 5.6% (74/1331) and 7.8% (104/1331) 
for any species.
A total of 1331 patients had a complete first screen of both RDT 
and blood film. The blood film and RDT strategy identified all P. fal-
ciparum infections (see Table 2). This gave sensitivity and specificity 
of 100% (95% CI = 95.0% to 100%) and 99.4% (95% CI = 98.9% to 
99.8%), respectively.
The blood film and RDT strategy did not identify all Plasmodium 
spp. infections; there was one false negative. The false- negative 
case was admitted and subsequently found to be positive on a se-
rial screen conducted 14 hours later. The second screen also had a 
negative RDT but the film detected P. ovale. This gave sensitivity and 
specificity of 99.0% (95% CI = 94.8% to 100%) and 99.5% (95% CI = 
98.9% to 99.8%), respectively.
DISCUSSION
Our findings suggest that negative results for the RDT and blood 
film, following a single blood test in the ED, excludes malaria suffi-
ciently well to enable a safe diagnostic pathway when combined with 
safety netting. With the use of appropriate safety netting, advising 
patients strongly to return for follow- up testing if their symptoms 
persist, routine serial sampling for 3 days on every patient would 
not be required. In our study population this does not appear to in-
crease the risk of a missed diagnosis and has the advantage of re-
ducing inconvenience for patients and improving efficiency of health 
services. This study showed that there was already a reluctance of 
patients to reattend, and within the study period we did not find an 
increased risk for patients after a single screen with RDT and thin 
smear. We demonstrated an excellent sensitivity for P. falciparum of 
1.00 (95% CI = 0.95 to 1.00) in our cohort of patients, with a mean 
parasitemia of 33,500 parasites/µL. Crucially, it was not sufficient to 
exclude all species of malaria, but the sensitivity was still high 99.0 
(95% CI = 94.8 to 100). Given the far greater severity of P. falciparum 
versus P. vivax, P. ovale, and P. malariae (though not P. knowlesi), this is 
F I G U R E  1  STARD diagram of study participants for 
P. falciparum. The national opt- out registry is cross- referenced 
when retrospective research is conducted NHS databases; any 
participants who have preemptively indicated that they do not wish 
to participate in research are excluded [Color figure can be viewed 
at wileyonlinelibrary.com]
TA B L E  1  Baseline characteristics
Population
Malaria 
absent P. falciparum present
Age (y) 29 (12– 44) 35 (24– 45)
Male 604 (49.2) 60 (81.1)
Non- UK residents 1014 (82.6) 41 (55.4)
Prevalence — 74 (5.6)
Parasitemia (parasites/
µL), mean (95% CI)
— 33,600 (24,500– 42,700)
Parasitemia — 37,500 (5,000– 45,000)
Note: Data are reported as median (IQR) or n (%), unless otherwise 
reported.
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an advantageous diagnostic profile. Furthermore, the false- negative 
case was already admitted on clinical grounds and therefore came 
to no harm.
For those sent home from EDs, appropriate safety netting must 
be provided. Preferably this would be in a written form (see Data 
Supplement S1, available as supporting information in the online 
version of this paper, which is available at http://onlin elibr ary.wiley.
com/doi/10.1111/acem.14216/ full), to ensure that those patients 
with a negative initial malaria screen whose illness continues in the 
absence of a viable alternative diagnosis present expediently for re-
evaluation, including another malaria test.
The benefit of early exclusion of malaria is not only one of pa-
tient safety and satisfaction. There is a strong economic argument 
for where it is clinically safe to do so, in reducing the number of fol-
low- up appointments. An outpatient visit has an economic cost to 
the hospital, £120,9 and to the patient's economic activity, £59.10 If 
each patient were to have three screens, the estimated total excess 
cost in this cohort would have been £441,107.
Rossi et al.11 similarly examined the use of RDTs and blood films in 
combination to detect malaria in returning travelers to Switzerland, 
but they did not calculate any diagnostic accuracy statistics, possi-
bly due to the lack of a reference standard. A multistage diagnos-
tic process has been examined by Murungi et al.12 in an endemic 
population. They reported a mean parasitemia of 4410 parasites/
µL (95% confidence interval 3,120 to 6,449 parasites per microli-
ter).12 This included thin and thick films and then RDT adjudicated 
by polymerase chain reaction (PCR). A sequential testing regimen 
was used where only indeterminate RDT tests receive microscopy, 
with positive and negative RDT results being upheld. In a population 
with a mean parasitemia of 5000 parasites/µL (0.1%), they demon-
strated a sensitivity of 95.5% (95% CI = 90.5% to 98.0%). In isolation, 
Gatti et al.13 found that in the detection of P. falciparum the RDT 
BinaxNOW, the technology of interest in this study, was 100% sen-
sitive when compared to microscopy in a sample of 306 with a prev-
alence of 47.2% and a mean parasitemia of 1.12% (range = 0.001% to 
16.0%; 56,000 parasites/µL [range = 50 to 800,000 parasites/µL]).
There is concern that HRP- 2– based RDTs, such as the one used 
in this study, may fail to detect clinical cases of P. falciparum due to 
deletion of the HRP- 2 and/or HRP- 3 genes. Mussa et al.14 examined 
a Sudanese population and found that nine of 26 samples were neg-
ative for the gene, this appears to vary by region as Bharti et al.15 
found a rate of one in 1392 in Indian samples, and there were four of 
93 in the analysis by Li et al.16 of samples from the China– Myanmar 
border. In the Amazon region of Peru and contiguous areas and in 
Eritrea, P. falciparum with HRP- 2 and/or HRP- 3 gene deletions are 
sufficiently common that RDTs based on alternative malaria antigens 
(albeit with lower sensitivity) have had to be introduced.17 Despite 
this evidence, this evaluation does not appear to support the notion 
of inadequate sensitivity of HRP- 2– based assays in the returning 
traveler.
Looking forward for malaria diagnostics, loop- mediated isother-
mal amplification (LAMP) provides a powerful alternative for point of 
care detection. Mohon et al.18 used a biobank (50:50, positive:nega-
tive) to assess the accuracy of LAMP and found 100% sensitivity. In a 
study of LAMP for the diagnosis of imported malaria at the Hospital 
for Tropical Diseases in London, it demonstrated diagnostic sensi-
tivity significantly superior to that of expert microscopy and close 
to that of nested PCR.19 Unlike malaria microscopy, its performance 
does not require lengthy training and LAMP has the potential to re-
place microscopy as the primary malaria screen in settings like the 
one described in this study, contributing greater confidence to the 
efficacy of a single visit strategy.
LIMITATIONS
The verification of negative results and subsequent detection of 
false negatives is a limitation of this study. To conduct this retro-
spective review we assumed that patients with untreated malaria 
would likely re- present to health care, particularly if they had P. fal-
ciparum. We could detect re- presentations by the laboratory route 
as diagnostic laboratories are required to report positive malaria 
tests to PHE. A capture– recapture study showed that the PHE 
MRL) surveillance system captures 56% (95% CI = 54% to 58%) of 
malaria cases,20 similar to that in other industrialized countries.21 
Ascertainment for P. falciparum was higher at 66% in the MRL study, 
so we would expect to detect a significant proportion of any cases 
missed in the malaria tests conducted in our unit.
This study was retrospective and as such is prone to selection 
and information bias. It is also the case that the single visit efficacy 
defined in this study depends on the availability of accurate labo-
ratory diagnostic performance in morphologic diagnosis. The wider 
application of these findings requires a laboratory staff with suffi-
cient skill and experience. This may not be the case in smaller hospi-
tals so requires risk assessment before implementation in any single 
entre.
CONCLUSION
A single thin film and rapid diagnostic test is likely to be sufficient 






P. falciparum 100 (95.1– 100) 99.4 (98.9– 99.8) 100 (99.7– 100) 91.4 (83.0– 96.5)
Any malaria 99.0 (94.8– 100) 99.5 (98.9– 99.8) 99.9 (99.5– 100) 94.5 (88.4– 98.0)
Note: Data are reported as % (95% CI).
TA B L E  2  Diagnostic accuracy statistics 
of a blood film and RDT strategy for the 
diagnosis of P. falciparum and any species
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important caveats. The sensitivity of this screen and the detection 
of false negatives relies on the reattendance of patients. As such a 
prospective study should be conducted to further assess the safety 
of such an approach.
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